Skip to content

German Cancer Aid

Request correction

Professional services

Unclaimed

German Cancer Aid is a privately funded German nonprofit organization supporting cancer prevention, research, treatment, patient services, rehabilitation, and public information.

Last updated August 26, 2026

AI crawler reads

No AI crawler has read this profile yet.

Overview

German Cancer Aid, known in German as Deutsche Krebshilfe, is a German nonprofit organization dedicated to combating cancer across prevention, diagnosis, treatment, after-care, research, and patient support. It was established in Bonn on September 25, 1974, by Mildred Scheel, a physician and the wife of then Federal President Walter Scheel. From its foundation, the organization was designed to rely on private donations rather than regular public financing. This funding model supports its stated independence from political institutions and the pharmaceutical industry. The organization operates under the motto “Help. Research. Information.” Its work combines direct assistance for people affected by cancer with support for the wider medical and public-health system. It funds research projects intended to improve cancer prevention, diagnostic methods, therapies, rehabilitation, psychosocial care, and survivorship. It also contributes to improvements in hospital equipment and staffing and can respond to shortages or urgent needs in treatment, research, and rehabilitation institutions. A major part of German Cancer Aid’s public-facing role is the production and distribution of accessible health information. It publishes material on different forms of cancer, risk reduction, early detection, treatment choices, rehabilitation, and self-help. The organization also supports educational courses, professional training, medical information events, and public-awareness activities designed to encourage prevention and appropriate medical check-ups. Its information resources are generally offered without charge. German Cancer Aid provides advice to cancer patients and families, including assistance for people experiencing financial hardship because of illness. In appropriate cases, the organization can provide direct financial support. Its patient-oriented activities are complemented by the Dr. Mildred Scheel Foundation for Cancer Research, which supports innovative projects seeking better methods of cancer diagnosis and treatment. The organization has developed an institutional network that includes the Dr. Mildred Scheel Foundation for Cancer Research, Mildred Scheel Kreis e.V., and the Dr. Mildred Scheel Academy for Education and Research in Cologne. Its headquarters are in Bonn, with an additional office in Berlin for contact with federal ministries, parliament, and national policy stakeholders. German Cancer Aid is also involved in professional and scientific cooperation. In 2014, it worked with the German Cancer Society for the first time in organizing the German Cancer Congress. The congress is a major European forum for oncology, bringing together specialists in cancer diagnostics, therapy, research, prevention, and patient care. Through fundraising, research sponsorship, service development, professional education, and public communication, German Cancer Aid functions as one of Germany’s prominent independent cancer-fighting organizations.

History

German Cancer Aid was founded in Bonn on September 25, 1974, by Mildred Scheel. The organization emerged during the period when her husband, Walter Scheel, served as Federal President of Germany. Its founding purpose was to create a broad, independent institution capable of addressing cancer not only through medical research but also through prevention, patient assistance, public education, and improvements to care institutions. From the beginning, German Cancer Aid adopted a private-donation funding model. This was intended to preserve independence from political bodies and the pharmaceutical industry and to allow the organization to direct resources toward cancer-related needs identified through its own charitable and scientific priorities. Its central motto, “Help. Research. Information.”, reflects the three connected areas of its work. The organization’s grant-making and institutional support activities cover cancer prevention, diagnosis, therapy, rehabilitation, after-care, and self-help. It finances and supports research projects aimed at developing better diagnostic procedures and treatments. It also helps hospitals and other treatment, research, and rehabilitation institutions address shortages in equipment and personnel. These activities position German Cancer Aid between a conventional charitable fundraiser, a research sponsor, and a health-information organization. Patient support has remained another central component. People with cancer who experience financial distress may seek advice and, in suitable cases, direct financial assistance. The organization also promotes psychosocial support, self-help, rehabilitation, and access to understandable information about different cancer types and treatment options. Its public-information work encourages prevention and participation in medical check-ups, while professional education and information events seek to improve the knowledge of healthcare workers and the general public. The organization expanded its institutional structure through affiliated entities. The Dr. Mildred Scheel Foundation for Cancer Research was founded in 1976. Mildred Scheel Kreis e.V. followed in 1977, and the Dr. Mildred Scheel Academy for Education and Research GmbH in Cologne was established in 1992. Together, these bodies extend German Cancer Aid’s activities into research funding, supporter relations, training, and professional development. German Cancer Aid’s headquarters are in Bonn, while a Berlin office supports contact with federal government and parliamentary institutions. The organization has also maintained a visible role in cancer communication and advocacy through brochures, media work, public campaigns, and educational events. Its information department has been described as a major part of its public identity because the organization makes cancer information broadly available without charge. Leadership has included public figures and prominent medical specialists. Mildred Scheel was the founding figure, and later presidents included cancer researcher Harald zur Hausen and journalist and broadcaster Fritz Pleitgen. The organization’s management and board have also included cancer experts and administrators responsible for coordinating research, patient services, communications, and institutional support. A notable development in its professional collaboration occurred in 2014, when German Cancer Aid and the German Cancer Society cooperated for the first time in organizing the German Cancer Congress. The event addressed interdisciplinary cancer care, the integration and financing of medical innovations, and the increasing individualization of treatment decisions following molecular-genetic diagnosis. This cooperation illustrated German Cancer Aid’s role in connecting public fundraising and patient advocacy with the professional oncology community. Today, German Cancer Aid remains a Germany-focused nonprofit cancer organization. Its activities span donor-funded research, cancer prevention, patient counseling and assistance, free information, public-awareness work, and support for healthcare and rehabilitation institutions. Detailed current leadership, financial figures, and program-level outcomes require confirmation from the organization’s latest official publications.

  • 2014

    First cooperation with the German Cancer Society on the German Cancer Congress

    [1]

    German Cancer Aid and the German Cancer Society jointly organized the German Cancer Congress for the first time.

  • 1992

    Dr. Mildred Scheel Academy established

    [1]

    The Dr. Mildred Scheel Academy for Education and Research GmbH was established in Cologne to support education and professional development.

  • 1977

    Mildred Scheel Kreis established

    [1]

    Mildred Scheel Kreis e.V. was established as an affiliated association.

  • 1976

    Dr. Mildred Scheel Foundation for Cancer Research established

    [1]

    The affiliated foundation was created to support innovative cancer research and improved diagnostic and therapeutic approaches.

  • 1974

    German Cancer Aid founded

    [1]

    Mildred Scheel founded German Cancer Aid in Bonn on September 25 as a privately funded organization dedicated to fighting cancer.

Products and positioning

An independent, donation-funded national cancer charity combining patient assistance, cancer research funding, prevention, public education, and support for medical institutions.

  • Health education

    Cancer information materials

    German Cancer Aid produces and distributes public information on cancer types, prevention, early detection, diagnosis, treatment, rehabilitation, after-care, and self-help. These materials are intended to make complex medical topics understandable to patients, families, and the general public and are generally available without charge.

  • Patient support

    Patient counseling and financial assistance

    The organization advises people affected by cancer and can provide financial support in appropriate cases, particularly where illness has created severe economic hardship. This service complements medical treatment with practical and social assistance.

  • Research grants · 1976

    Cancer research funding

    Through German Cancer Aid and the Dr. Mildred Scheel Foundation for Cancer Research, the organization supports research into prevention, diagnosis, treatment, rehabilitation, and new therapeutic methods. The program is intended to advance oncology while addressing areas that may not be fully covered by conventional funding.

  • Healthcare infrastructure

    Institutional support for oncology care

    German Cancer Aid helps hospitals, research centers, treatment facilities, and rehabilitation institutions address shortages in equipment and personnel. Support is directed toward improving the practical capacity and quality of cancer care.

  • Medical education · 1992

    Professional education and information events

    The organization supports training courses, medical education, public information events, and related activities intended to improve knowledge among healthcare professionals and the public. The Dr. Mildred Scheel Academy forms part of this wider education and research network.

Marketing campaigns

  • Cancer prevention and early-detection information campaigns

    Germany

    German Cancer Aid conducts public-facing information and media activities explaining cancer risks, prevention, early detection, and the importance of appropriate medical check-ups.

    Outcome. Specific campaign metrics are not identified in the cited reference material.

  • Cancer information and patient education program

    Germany

    The organization’s information department develops free brochures and related resources covering different cancers, treatment options, rehabilitation, and self-help.

    Outcome. The program established free cancer information as a prominent part of the organization’s public service role.

Brand decisions

  • 2014

    Cooperation with the German Cancer Society on the German Cancer CongressOther

    Background

    The German Cancer Aid and German Cancer Society were both major institutions in German oncology, with complementary expertise in public support, research, professional practice, and cancer care.

    Action taken

    They cooperated for the first time in organizing the German Cancer Congress in Berlin.

    Aftermath

    The congress brought together specialists to discuss interdisciplinary care, the integration and financing of innovation, and individualized treatment decisions based on molecular-genetic diagnosis.

  • 1974

    Adoption of private-donation funding and institutional independenceStrategy

    Background

    German Cancer Aid was created to fight cancer across research, prevention, patient care, and public information while remaining independent of political institutions and the pharmaceutical industry.

    Action taken

    The organization relied on private donors from its foundation rather than positioning itself as a government-funded or industry-controlled body.

    Aftermath

    Private fundraising became a defining feature of the organization’s identity and operating model.

Sources2 sources

Cite this profile: Cite the canonical profile. /brand-wiki/german-cancer-aid · Editorial policy · How profiles are compiled